G
GenomSys
Solutions and Systems for Efficient Genomic Information Processing
About GenomSys
GenomSys is a Swiss-based startup that operates in the genomic data processing market. The company has developed a toolkit that implements the new ISO/IEC 23092 MPEG-G standard, a technology that allows for more efficient processing and transmission of genomic data. This toolkit is CE-marked as an In-Vitro Diagnostic (IVD) medical device, meaning it has met the European Union's stringent safety, health, and environmental protection requirements.
Read full description
GenomSys' primary clients are organizations that handle genomic data, such as genomic diagnostic laboratories. The company's toolkit can be integrated with sequencing machines, resulting in smaller files and faster data transmission. This allows for accelerated time-to-market for genomic applications. Additionally, the toolkit can be interfaced with genomic tertiary analysis applications, enabling manufacturers to focus on their core competencies.
The company's business model revolves around providing software solutions to genomic professionals. These solutions are developed by a multicultural team of geneticists, bio-informaticians, mobile developers, and software engineers. The company prides itself on the quality of its products, which are developed with Swiss precision and are ISO-13485-certified.
GenomSys generates revenue by selling its software solutions to genomic professionals and organizations. The company's products are not only efficient and reliable but also user-friendly, requiring no onboarding or IT expertise. This makes them an attractive option for genomic diagnostic laboratories, which can benefit from faster data upload and processing, as well as reliable annotation via access to Varsome’s curated database.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Lausanne, Switzerland
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 50.6/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Security, Biotechnology, Compression, Genetics and genomics, Core AI, Spinout, Biotech and Pharma
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Jul 2018
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2019 | $9.4M | $37M | Dolby Family Ventures · Preon Capital Partners · Investors' club | — |
| GRANT✓Other financing | Mar 2019 | $528K | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for GenomSys is 1.3K monthly website visits, down 35% over the last three months. GenomSys's team declined 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A3 investors entered at this stage
Preon Capital Partners
Dolby Family Ventures
Investors' club
Other known investors1 additional known investor
EPFL Swiss Federal Polytechnic School of Lausanne
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GenomSys on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GenomSys’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.